OmniAb (OABI) Goodwill & Intangibles (2021 - 2026)
OmniAb (OABI) reported Goodwill & Intangibles of $203.1 million for Q1 2026, down 7.18% year-over-year from $218.8 million in Q1 2025, and down 2.88% quarter-over-quarter from $209.1 million in Q4 2025.
OmniAb (OABI) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Goodwill & Intangibles data on file, last reported at $203.1 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $203.1 million, down 7.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $203.1 million (down 7.18% YoY), and the FY2025 annual result was $209.1 million, down 5.81% from the prior year.
- Goodwill & Intangibles retreated to $203.1 million in Q1 2026 per OABI's latest filing, from $209.1 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $251.2 million in Q4 2022 and troughed at $203.1 million in Q1 2026.
- A 5-year average of $228.9 million and a median of $229.8 million in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles decreased 3.49% in 2022, then fell 7.3% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $251.2 million in 2022, then decreased by 4.69% to $239.4 million in 2023, then fell by 7.27% to $222.0 million in 2024, then declined by 5.81% to $209.1 million in 2025, then dropped by 2.88% to $203.1 million in 2026.
- Business Quant data shows OABI's Goodwill & Intangibles at $203.1 million in Q1 2026, $209.1 million in Q4 2025, and $212.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.10 Mn |
| Dec 31, 2025 | 209.13 Mn |
| Sep 30, 2025 | 212.36 Mn |
| Jun 30, 2025 | 215.58 Mn |
| Mar 31, 2025 | 218.81 Mn |
| Dec 31, 2024 | 222.04 Mn |
| Sep 30, 2024 | 228.10 Mn |
| Jun 30, 2024 | 231.49 Mn |
| Mar 31, 2024 | 236.03 Mn |
| Dec 31, 2023 | 239.45 Mn |
| Sep 30, 2023 | 242.75 Mn |
| Jun 30, 2023 | 245.90 Mn |
| Mar 31, 2023 | 248.33 Mn |
| Dec 31, 2022 | 251.22 Mn |
| Dec 31, 2021 | 260.30 Mn |